Response to FDA Adverse Event Reporting System (FAERS) Essentials: A Reflection on Study Conception is a research paper published in Clinical Pharmacology & Therapeutics (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural FDA HHS
Grant: FD999999
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords